49 / 164
ESTRO SCHOOL
49
ROADMAP
Hans Langendijk
Wolfgang Dörr
MULTIMODAL CANCER TREATMENT
RADIATION ONCOLOGIST, RADIATION THERAPIST
FACULTY
COURSE DIRECTOR
Wolfgang Dörr,
Radiation Biologist, Medical University of
Vienna, Vienna (AT)
COURSE CO-DIRECTOR
Hans Langendijk,
Radiation Oncologist, University Medical
Centre Groningen, Groningen (NL)
TEACHERS
• Nicolaus Andratschke,
Radiation Oncologist, University
Hospital Rostock, Rostock (DE)
• Jervoise Andreyev,
Gastroenterologist, The Royal Marsden
Hospital, London (UK)
• Karin Dieckmann,
Radiation Oncologist, University Hospital
Vienna, Vienna (AT)
• Sjoukje Oosting,
Medical Oncologist, University Medical
Center Groningen, Groningen (NL)
• John Ramage,
Lead clinician, Kings Health Partners
Neuroendocrine Centre, Kings College London; Professor of
Healthcare Research University of Winchester, Winchester
(UK)
PREREQUISITES
Before commencing this course participants should
have basic experience with patients experiencing adverse
events of radio(chemo)therapy.
TEACHINGMETHODS
• >15 hours of lectures
• >2 hours of case discussions
• 1 hour of general discussion.
METHODS OF ASSESSMENT
• MCQ
• Evaluation form
• Clinical case discussions.
KEYWORDS
Cancer survivorship, morbidity, quality-of-life.
FURTHER READING
Please consult the ESTRO website page of this course
for further information.
ACCREDITATION
Application for CME recognition will be submitted to
the European Accreditation Council for Continuing
Medical Education (EACCME), an institution of the
European Union of Medical Specialists (UEMS). EAC-
CME credits are recognised by the American Medical
Association towards the Physician’s Recognition Award
(PRA). Information on the status of the applications
can be obtained from the ESTRO office.